The relationship between vaginal pH, microflora, and yeast infection was investigated in 93 women randomly treated with either nystatin or miconazole pessaries and cream for two weeks. The vaginal pH was measured in a control group of 48 women. In the study group, 37 patients defaulted, 39 were cured, and 17 required treatment during the six-month follow-up period. In both study and control groups before and after treatment the mean vaginal pH was in the range of 4* 3-4*6. Lactobacilli were plentiful in 78 (91 07o) out of 86 patients and shows that lactobacilli and yeasts commonly coexist. The influence of other organisms appeared to be negligible. The trial showed that nystatin and miconazole were equally effective in the treatment of vaginal yeast infection and that the broad-spectrum activity of miconazole offered no advantage in this condition.
Introduction
Several previous reports have been published concerning the relationship between vaginal yeasts, other microflora, and their effects on pH. Peeters and his co-workers' found a higher pH (in the lateral fornix) in patients with clinical signs or symptoms of candidal vaginitis than in controls, but not all patients had the diagnosis confirmed by culture. They also concluded that there was no correlation between pH, symptoms, and the number of colonies of pathogens, but an inverse relationship between the presence of candida and lactobacilli was found. Cohen2 demonstrated a lower pH in the posterior fornix in women with clinical vaginitis than in controls. Both studies included some pregnant women and women with other vaginal pathogens and are therefore not directly comparable, but they do indicate conflicting results concerning vaginal pH and the presence of yeasts.
In the present study, our aim was to monitor the changes in pH values in a group of women with yeast infection in response to treatment. We also examined changes in pH values in relation to the menstrual cycle and the use of oral contraceptives. At the same time we assessed the vaginal flora and its changes in response to therapy with the standard antifungal agent, nystatin, and a newer broad-spectrum imidazole derivative, miconazole, with activity against a wide range of fungi and some Grampositive bacteria.
Patients and methods

STUDY GROUP
The study group The mean pH of the study group was 4-6 (Table  II) . No patient was menstruating at the time of diagnosis. Three patients had trichomoniasis and one gonorrhoea; there was only one woman whose partner had non-specific urethritis and she also had trichomonal infection both before and after initial treatment for yeast infection. In the study group, neither the outcome of treatment nor the drug given was related to, or had an effect on, vaginal pH (Table  III) . (Table II) . No patient was menstruating at the time of examination. None was infected with yeasts, trichomonads, or gonococci; three patients were sexual contacts of men with non-specific urethritis. No variation in pH was found throughout the menstrual cycle and there was no relationship with oral contraception (Table  IV) .
TREATMENT (STUDY GROUP)
The outcome of treatment is shown in Table V .
Vaginal infection recurred within six months in 11 (12%) patients, who were treated with nystatin and in The distribution throughout the samples was variable. No predominant organism was found in specimens with scanty or no lactobacilli, but followup specimens from this group showed the recurrence of lactobacilli in three of four patients investigated after treatment.
No notable change in microflora was found after treatment in the other groups examined.
Discussion
The question of the relationship between vaginal pH values and morbidity due to C albicans and other infections has produced conflicting reports with regard to the benefit of a low vaginal pH. Our work has indicated no relationship between vaginal pH over the range observed in 93 patients and 48 controls (pH 3 6-6 5) and vaginal morbidity due to yeast infection. Thus the protective effect of vaginal acidity does not appear to be confined to a critical range above or below which there is increased susceptibility to vaginal infection.
A relationship between the numbers of lactobacilli and vaginal acidity, however, is clearly shown and is consistent with the physiological role of the organism in maintaining a low pH in the vagina. Moreover, it appears that the part played by other organisms in the vagina rarely assumes importance, even when the pH value is at the higher end of the range observed. Increasing dominance of any organism normally considered commensal may lead to an inflammatory vaginal reaction, but this did not occur in our experience among patients with candidal infection.
Treatment with both drugs was highly effective in the short term, with mycological cure in all but three who returned for follow up at one month (a cure rate of 9130o with nystatin and of 94-70%o with miconazole). Comparison of cure rates subsequently is increasingly invalidated by an inability to distinguish treatment failure from reinfection with further yeasts.
